Windward Capital Management CO Amgen Inc Transaction History

Windward Capital Management CO

$1.14 Billion
Q2 2024

A detailed history of Windward Capital Management CO transactions in Amgen Inc stock. As of the latest transaction made, Windward Capital Management CO holds 21,683 shares of AMGN stock, worth $6.93 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

21,683

Previous 22,037 1.61%

Holding current value

$6.93 Million

Previous $6.27 Million 8.12%

% of portfolio

0.59%

Previous 0.55%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $93,013 - $113,035	-354 Reduced 1.61%	21,683 $6.77 Million
Q1 2024 Sep 20, 2024	BUY	$268.87 - $324.56 $95,179 - $114,894	354 Added 1.63%	22,037 $6.27 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $19,896 - $24,017	-74 Reduced 0.33%	22,037 $6.27 Million
Q4 2023 Oct 03, 2024	SELL	$255.7 - $288.46 $9,972 - $11,249	-39 Reduced 0.18%	22,111 $6.37 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $9,972 - $11,249	-39 Reduced 0.18%	22,111 $6.37 Million
Q3 2023 Oct 03, 2024	BUY	$218.65 - $271.46 $102,109 - $126,771	467 Added 2.15%	22,150 $5.95 Million
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $56,630 - $70,308	-259 Reduced 1.16%	22,150 $5.95 Million
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $23,783 - $28,124	-111 Reduced 0.49%	22,409 $4.98 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $71,349 - $86,963	316 Added 1.42%	22,520 $5.45 Million
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $5,611 - $6,328	25 Added 0.11%	22,204 $5.01 Million
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $30,453 - $33,889	132 Added 0.6%	22,179 $5.4 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $11,402 - $12,613	-52 Reduced 0.24%	22,047 $5.33 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $5,369 - $6,145	27 Added 0.12%	22,099 $4.97 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $12,099 - $14,175	-57 Reduced 0.26%	22,072 $4.69 Million
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $13,547 - $15,030	-58 Reduced 0.26%	22,129 $5.39 Million
Q1 2021 Apr 15, 2021	SELL	$221.91 - $258.6 $11,095 - $12,930	-50 Reduced 0.22%	22,187 $5.52 Million
Q4 2020 Jan 21, 2021	SELL	$216.38 - $257.67 $672,725 - $801,096	-3,109 Reduced 12.27%	22,237 $5.11 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $88,463 - $98,378	-377 Reduced 1.47%	25,346 $6.44 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $56,969 - $69,909	-288 Reduced 1.11%	25,723 $6.07 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $180,599 - $239,524	-991 Reduced 3.67%	26,011 $5.27 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $27,057 - $34,777	-143 Reduced 0.53%	27,002 $6.51 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $1,044 - $1,251	-6 Reduced 0.02%	27,145 $5.25 Million
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $71,514 - $83,830	-429 Reduced 1.56%	27,151 $5 Million
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $3,255 - $3,669	18 Added 0.07%	27,580 $5.24 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $24,976 - $29,155	140 Added 0.51%	27,562 $5.37 Million
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $44,284 - $49,924	-239 Reduced 0.86%	27,422 $5.69 Million
Q2 2018 Jul 12, 2018	SELL	$166.05 - $186.51 $15,442 - $17,345	-93 Reduced 0.34%	27,661 $5.11 Million
Q1 2018 Apr 12, 2018	SELL	$169.43 - $198.0 $6,099 - $7,128	-36 Reduced 0.13%	27,754 $4.73 Million
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $27,343 - $30,551	-162 Reduced 0.58%	27,790 $4.83 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $4.68 Million - $5.34 Million	27,952	27,952 $5.21 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Windward Capital Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Windward Capital Management CO with notifications on news.

Account

Windward Capital Management CO Amgen Inc Transaction History